Andrej Spec, MD, MSCI, FIDSA, FECMM
Washington University in St. Louis
H-index: 25
North America-United States
Top articles of Andrej Spec, MD, MSCI, FIDSA, FECMM
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Incidence and Mortality of COVID-19-Associated Invasive Fungal Infections Among Critically Ill Intubated Patients: A Multicenter Retrospective Cohort Analysis | JCZ Moya B Papadopoulos A Mansoor PB Mazi AM Rauseo | 2022/12/7 | |
Infectious Diseases Physician Management of Cryptococcal Meningitis in North America–Is Single High-Dose Liposomal Amphotericin B Being Used? | Open Forum Infectious Diseases | Nathan C Bahr Susan E Beekmann Philip M Polgreen Jeremey B Walker Andrej Spec | 2024/3/4 |
MSG-15: Super-Bioavailability Itraconazole Versus Conventional Itraconazole in the Treatment of Endemic Mycoses—A Multicenter, Open-Label, Randomized Comparative Trial | Open forum infectious diseases | Andrej Spec George R Thompson Marisa H Miceli Justin Hayes Laurie Proia | 2024/3 |
Description of Cryptococcosis Following SARS-CoV-2 Infection: A Disease Survey Through the Mycosis Study Group Education and Research Consortium (MSG-19) | Clinical Infectious Diseases | Jeremey Walker Todd McCarty Gerald McGwin Eloy E Ordaya Paschalis Vergidis | 2023/9/15 |
Shared Vision for Improving Outcomes for Serious Fungal Diseases: Report of a Patient, Caregiver, and Clinician Summit | Open Forum Infectious Diseases | Rob Purdie Lisa A Tushla Jonathan Ferretti Gonzalo Castro Ricky Watson | 2024/4/26 |
Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM | Martin Hoenigl Jon Salmanton-García Thomas J Walsh Marcio Nucci Chin Fen Neoh | 2021/8/1 | |
Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19: A Secondary Analysis of the ACTIV-1 IM Randomized Clinical Trial | JAMA Network Open | Stephen J Balevic Daniel K Benjamin William G Powderly P Brian Smith Daniel Gonzalez | 2024/4/1 |
1586. Impact of Dolutegravir-based Regimen on Metabolic Syndrome and its Components in Adults with HIV in Care at Hospital Roosevelt in Guatemala City | Open Forum Infectious Diseases | Alvaro J Mazariegos Farfán Hugo Marroquin Dean Ortiz Luis Parra-Rodriguez Andrej Spec | 2023/12 |
Advanced concept of efficient use of transformers leveraging the dynamic thermal rating technology | Andrej Souvent Miha Rot Tim Gradnik Andrej Spec Polona Koprivc | 2023/1/1 | |
Management of HIV-Associated Cryptococcal Meningitis | Matthew R Osborn Andrej Spec Patrick B Mazi | 2023/6 | |
2883. Comparative outcomes following Candida bloodstream infections in patients with left ventricular assist devices (LVAD) | Open Forum Infectious Diseases | Armaghan-e-Rehman Mansoor Gayathri Krishnan Julio C Zuniga-Moya Dorothy Sinclair Andrej Spec | 2023/12 |
MAJOR ARTICLE | Joseph E Levitt Haley Hedlin Sophie Duong Di Lu Justin Lee | 2023 | |
Prevalence of ocular complications in candidemia: defining the “battlefield” | Adriana M Rauseo Andrej Spec | 2023/5/15 | |
Single high dose of liposomal amphotericin B in human immunodeficiency virus/AIDS-related disseminated histoplasmosis: a randomized trial | Clinical Infectious Diseases | Alessandro C Pasqualotto Daiane Dalla Lana Cassia SM Godoy Terezinha do Menino Jesus Silva Leitão Monica B Bay | 2023/10/15 |
Corticosteroids increase the risk of invasive fungal infections more than tumor necrosis factor-alpha inhibitors in patients with inflammatory bowel disease | Crohn's & Colitis 360 | Martin H Gregory Andrej Spec Dustin Stwalley Anas Gremida Carlos Mejia-Chew | 2023/4/1 |
Spatial epidemiologic analysis and risk factors for nontuberculous mycobacteria infections, Missouri, USA, 2008–2019 | Carlos Mejia-Chew Miguel A Chavez Min Lian Angela McKee Leighton Garrett | 2023/8 | |
The geographic distribution of dimorphic mycoses in the United States for the modern era | Clinical Infectious Diseases | Patrick B Mazi John M Sahrmann Margaret A Olsen Ariella Coler-Reilly Adriana M Rauseo | 2023/4/1 |
Abatacept, cenicriviroc, or infliximab for treatment of adults hospitalized with COVID-19 pneumonia: a randomized clinical trial | JAMA | Jane A O’Halloran Emily R Ko Kevin J Anstrom Eyal Kedar Matthew W McCarthy | 2023/7/25 |
Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial | The Lancet | George R Thompson Alex Soriano Oliver A Cornely Bart Jan Kullberg Marin Kollef | 2023/1/7 |
Reply to Collis et al. | Open Forum Infectious Diseases | Adriana M Rauseo Andrej Spec | 2023/7 |
Co-Authors
